Forge Biologics assembles scientific and manufacturing advisory board
May 18, 2022 -- Forge Biologics has created its new Scientific and Manufacturing Advisory Board filled with leaders in the field of gene therapy development and manufacturing. This independent panel represents Forge’s commitment to enhancing its gene therapy offerings through insights from experts in the field. Read More
KromaTiD releases PinPoint FISH Probes to expand genomics solutions
May 18, 2022 -- KromaTiD has introduced its proprietary Pinpoint Fluorescence In Situ Hybridization (FISH) Probes to strengthen genomics research. The PinPoint FISH Probes build upon existing genomic assays while providing improved resolution and signal strength, while minimizing background noise. Read More
Precision BioSciences presents preclinical data for gene editing therapies
May 17, 2022 -- Precision BioSciences is scheduled to display preclinical data for its Arcus-based gene editing studies at the American Society of Gene & Cell Therapy’s annual meeting in Washington, DC. The showcase will include two oral presentations and two posters highlighting gene editing study results. Read More
PerkinElmer introduces ultrarapid whole-genome sequencing technology
May 17, 2022 -- PerkinElmer has launched a novel ultrarapid whole-genome sequencer to improve and accelerate diagnoses in intensive care settings. This ultrarapid whole-genome sequencing technology provided by PerkinElmer Genomics enables faster decision making for physicians, which is particularly important in critically ill patients. Read More
Lunaphore and Indica Labs combine spatial biology and pathology imaging platforms
May 13, 2022 -- Lunaphore and Indica Labs have partnered on the development of a biological research tool involving software from both companies. This new solution will involve a combination of Lunaphore’s Comet spatial biology platform and Indica Labs’ Halo digital pathology image analysis software. Read More
PrecisionLife, Sano Genetics partner on studying long COVID
May 12, 2022 -- PrecisionLife is joining forces with Sano Genetics to better understand the long-term effects of the coronavirus (long COVID). PrecisionLife’s proprietary combinatorial analytics platform will identify risk factors and potential drug targets by analyzing Sano Genetics’ data from 3,000 U.K. adults suffering from long COVID symptoms. Read More
Avantor and Cytovance enter into plasmid manufacturing agreement
May 11, 2022 -- Avantor and Cytovance Biologics have entered into an agreement to advance the manufacturing of plasmids. This agreement will combine Avantor’s expertise in providing cell and gene therapy materials with Cytovance’s plasmid DNA manufacturing capabilities. Read More
Thermo Fisher releases new qPCR solutions to improve biologics development
May 11, 2022 -- Thermo Fisher Scientific has launched a series of QualTrak quantitative polymerase chain reaction (qPCR) biopharma solutions to enhance the drug development process for biologics. The qPCR offerings include QuantStudio 6 and 7 Pro real-time PCR systems and TaqMan and TaqPath master mixes and assays. These innovations support biopharma companies developing these novel therapeutics over the course of the lifespan of the biologics. Read More
Quantori increases drug development efficiency with HPC Accelerator
May 10, 2022 -- Quantori has launched its High-Performance Computing (HPC) Accelerator to provide stronger computing capabilities to the drug discovery and development processes. Read More
Illumina and Deerfield Management enter into drug development partnership
May 9, 2022 -- Illumina and Deerfield Management have entered into a partnership to accelerate drug discovery and development using genetic technologies and artificial intelligence. The five-year partnership will utilize genetic knowledge to strategically invest in the clinical development of therapies with a high probability of success. Read More
Conferences
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter